Squarepoint
BNGO icon

Squarepoint’s Bionano Genomics BNGO Stock Holding History

Squarepoint’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-336
Closed -$22.4K – 4073
2024
Q1 		$22.4K Buy
336
+82
+32% +$6.12K ﹤0.01% 3922
2023
Q4 		$28.8K Buy
+254
New +$26.5K ﹤0.01% 3893
2022
Q3 		– Sell
-26
Closed -$21K – 3002
2022
Q2 		$21K Buy
+26
New +$26.8K ﹤0.01% 2769
2022
Q1 		– Sell
-864
Closed -$1.55M – 2848
2021
Q4 		$1.55M Buy
864
+247
+40% +$661K ﹤0.01% 1409
2021
Q3 		$2.04M Buy
617
+514
+499% +$1.8M 0.01% 1188
2021
Q2 		$452K Buy
+103
New +$407K ﹤0.01% 2220
2021
Q1 		– Sell
-90
Closed -$167K – 3134
2020
Q4 		$167K Buy
+90
New +$33.6K ﹤0.01% 2576

Other funds holding BNGO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
CCM
Coldstream Capital Management Bellevue, Washington $8.12B AUM 17.95% 1-Year Est. Return

Squarepoint's BNGO Position: Q2 2024 in Review

Squarepoint sold out of Bionano Genomics (BNGO) in Q2 2024, closing a stake of 336 shares — an estimated $22.4K sold.

Squarepoint first reported a position in BNGO in Q4 2020 and held it in 7 quarters. The position peaked at $2.04M in Q3 2021. 53 funds tracked by Wall St. Rank hold BNGO as of Q2 2024.

  • Squarepoint reported no remaining Bionano Genomics position as of Q2 2024 after selling out during the quarter.
  • Squarepoint sold 336 Bionano Genomics shares in Q2 2024, an estimated $22.4K.
  • Squarepoint first reported a position in Bionano Genomics in Q4 2020 and held it in 7 quarters.
  • Squarepoint's Bionano Genomics position peaked at $2.04M in Q3 2021.
  • 53 funds tracked by Wall St. Rank held Bionano Genomics as of Q2 2024.

Based on Squarepoint's 13F filing for Q2 2024, filed 14 Aug 2024.